Results for "HDA Factbook"
HDA Addresses DSCSA Data-Related Challenges In Healthcare Packaging Op-Ed
With the end of the 10-year-implementation of the Drug Supply Chain Security Act (DSCSA) fast approaching and significant work remaining for the supply chain, HDA’s Anita Ducca, Senior Vice President, Regulatory Affairs, and Elizabeth Gallenagh, General Counsel and Senior Vice President, Supply Chain Integrity co-authored a piece for Healthcare Packaging that examines the progress toward, challenges impacting and recommendations and requirements for full implementation.
Chip Davis Shares HDA’s 2025 Policy Priorities in Annual Chain Drug Review Column
In his annual “Health Care Outlook” column featured in Chain Drug Review, HDA’s President and CEO Chip Davis outlines a series of key policy priorities for healthcare distributors in 2025, as well as some challenges he expects the industry to face.
HDA Statement on Federal Trade Commission and Health and Human Services RFI on Drug Shortages
HDA commented on the release of an FTC and HHS Request for Information (RFI) investigating the causes of drug shortages.
HDA’s Emerging Leaders Program Helps Up-and-Coming Professionals Grow Their Careers
The pharmaceutical distribution sector is full of exciting opportunities for young professionals, whose fresh perspectives and innovative ideas will help enhance supply chain efficiency and security.